Characteristics of Patients With Tardive Dyskinesia Who Maintain Treatment Response After Discontinuing Long-Term Valbenazine: Pooled Analysis of Two Trials

被引:0
|
作者
Caroff, Stanley [1 ]
Lindenmayer, Jean-Pierre [1 ]
Farahmand, Khodayar [1 ]
Burke, Joshua [1 ]
Siegert, Scott [1 ]
机构
[1] Univ Penn, Moorestown, NJ USA
关键词
Valbenazine; Tardive Dyskinesia; Movement Disorders;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
T170
引用
收藏
页码:S321 / S321
页数:1
相关论文
共 50 条
  • [1] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    ANNALS OF CLINICAL PSYCHIATRY, 2023, 35 (01) : 3 - 3
  • [2] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    CNS SPECTRUMS, 2023, 28 (02) : 241 - 241
  • [3] Sustained Treatment Response with Long-Term Valbenazine in Patients with Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    NEUROLOGY, 2023, 100 (17)
  • [4] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farah-Mand, Khodayar
    Siegert, Scott
    Dunayevich, Eduardo
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 344 - 345
  • [5] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farahmand, Khodayar
    Siegert, Scott
    Dunayevich, Eduardo
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 344 - 345
  • [6] Treatment Responses with Long-Term Valbenazine in Patients with Tardive Dyskinesia
    Singer, Carlos
    Comella, Cynthia
    Marder, Stephen
    Farahmand, Khodayar
    Jimenez, Roland
    NEUROLOGY, 2020, 94 (15)
  • [7] Sustained Treatment Response and Global Improvements With Long-term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Citrome, Leslie
    Singer, Carlos
    Lindenmayer, Jean-Pierre
    Zinger, Celia
    Liang, Grace
    Dunayevich, Eduardo
    Marder, Stephen R.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (04) : 353 - 361
  • [8] Long-Term Outcomes in Patients with Tardive Dyskinesia who Were Early Responders with Valbenazine
    Factor, S.
    Comella, C.
    Marder, S.
    Burke, J.
    Farahmand, K.
    Siegert, S.
    MOVEMENT DISORDERS, 2019, 34 : S595 - S596
  • [9] Long-term effects of valbenazine on tardive dyskinesia in patients with a mood disorder
    McIntyre, R.
    Nierenberg, A.
    Farahmand, K.
    Burke, J.
    Siegert, S.
    BIPOLAR DISORDERS, 2018, 20 : 116 - 116
  • [10] Maintenance of Response After 4-Week Washout in Patients With Tardive Dyskinesia who Received Long-Term Treatment With Once-Daily Valbenazine
    Caroff, Stanley
    Marder, Stephen
    Lindenmayer, Jean-Pierre
    Farahmand, Khodayar
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 340 - 340